Hyperin inhibits nuclear factor kappa B and activates nuclear factor E2-related factor-2 signaling pathways in

Chia-Sheng Chao1, Chien-Sung Tsai2, Yee-Phoung Chang3

  • 1Division of Cardiovascular Surgery, Department of Surgery, Kaohsiung Armed Forces General Hospital, Kaohsiung 80284, Taiwan, ROC; School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan, ROC; Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan, ROC.